Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma
Antineoplastic Combined Chemotherapy Protocols
This regimen has promising activity in advanced colorectal cancer, particularly in patients with an Eastern Cooperative Oncology Group (ECOG) PS of 0 to 1.
Additional Document Info
has global citation frequency